|
業務類別
|
Biotechnology |
|
業務概覽
|
Rapport Therapeutics Inc is a clinical-stage biotechnology company dedicated to the discovery and development of small-molecule precision medicines for patients with neurological or psychiatric disorders. The company's portfolio of programs from its RAP technology platform includes RAP-219, an investigational small molecule being developed as a therapy for focal onset seizures, primary generalized tonic-clonic seizures, and bipolar mania. Additionally, it has two discovery-stage nicotinic acetylcholine receptor (nAChR) programs stemming from its RAP technology platform: one being developed for the treatment of chronic pain, and the second, being developed for the treatment of hearing disorders. Geographically, the company operates in the United States. |
| 公司地址
| 99 High Street, Suite 2100, Boston, MA, USA, 02110 |
| 電話號碼
| +1 857 321-8020 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.rapportrx.com |
| 員工數量
| 84 |
| Mr. Abraham N. Ceesay, M.B.A. |
Chief Executive Officer and Director |
美元 652.93K |
23/04/2026 |
| Dr. Jeffrey Sevigny, M.D. |
Chief Medical Officer |
美元 561.09K |
23/04/2026 |
| Mr. Troy A. Ignelzi |
Chief Financial Officer and Principal Accounting Officer |
美元 519.85K |
23/04/2026 |
| Dr. Swamy Yeleswaram, PhD |
Chief Development Officer |
-- |
23/04/2026 |
| Ms. Cheryl Gault |
Chief Operating Officer |
-- |
23/04/2026 |
| Mr. David Bredt, M.D.,PhD |
Chief Scientific Officer |
-- |
23/04/2026 |
|
|
| Dr. Ramiro Sanchez, M.D. |
Independent Director |
23/04/2026 |
| Dr. Wendy B. Young, PhD |
Independent Director |
23/04/2026 |
| Mr. Abraham N. Ceesay, M.B.A. |
Chief Executive Officer and Director |
23/04/2026 |
| Dr. Steven M. Paul, M.D. |
Chairman of the Board |
23/04/2026 |
| Dr. James I. Healy, M.D.,PhD |
Independent Director |
23/04/2026 |
| Dr. Reid M. Huber, PhD |
Director |
23/04/2026 |
| Dr. John M. Maraganore,PhD |
Independent Director |
23/04/2026 |
| Mr. Robert J. Perez |
Independent Director |
23/04/2026 |
| Mr. Paul M. Silva |
Independent Director |
23/04/2026 |
|
|
|
|
